TickerGuard
Buy Day today: Neutral (60) Mixed market breadth · no major macro event
OMER

Omeros Corporation

Healthcare · Biotechnology

18.60$ +0.8% vs. previous close Closing price · As of: Oct 2, 2026

Statements

Balance Sheet

All figures as a percentage of total assets in the same period.

Tick rows to compare them in a chart (up to 4)

Balance Sheet OMER
Line item 2005 2006 2007 2008 2009 2010 2011 2012 2013 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
– – 100.0% 100.0% 100.0% 100.0% 100.0% 100.0% 100.0% 100.0% 100.0% 100.0% 100.0% 100.0% 100.0% 100.0% 100.0% 100.0% 100.0% 100.0% 100.0%
– – 90.1% 94.5% 97.7% 95.7% 96.2% 92.9% 89.6% 82.6% 75.8% 89.6% 93.2% 93.7% 75.7% 83.6% 59.1% 75.0% 57.6% 48.4% 66.2%
– – 21.8% 58.7% 1.3% 7.2% 14.8% 5.7% 8.4% 3.2% 2.8% 3.3% 2.9% 6.1% 2.3% 5.8% 24.0% 1.9% 1.9% 1.2% 3.0%
– – 88.7% 92.2% 97.2% 91.9% 91.1% 84.1% 85.3% 62.1% 57.7% 67.4% 72.0% 63.1% 44.4% 74.5% 37.5% 33.0% 45.4% 32.5% 52.8%
– – 0.7% 1.0% 0.4% 3.2% 3.2% 7.3% 2.3% 3.5% 13.3% 17.9% 14.7% 23.8% 25.7% 2.1% 19.7% 41.0% 1.8% 13.3% 11.1%
– – – – – – 0.0% 0.0% 0.0% 5.1% 1.0% 1.7% 0.4% 54.7% 35.3% 63.3% 0.0% – 2.3% – –
– – 3.1% 4.2% 1.7% 3.5% 2.7% 3.9% 5.7% 7.1% 1.9% 1.8% 1.8% 4.0% 2.8% 15.5% 7.2% 3.9% – – –
– – – – – – 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% – – – – – – – –
– – 0.6% 0.3% – – 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% – – – – – – – –
– – 357.5% 520.5% 30.5% 55.2% 120.6% 907.4% 211.2% 484.6% 153.5% 155.7% 102.4% -4.4% 179.6% 166.7% 94.3% 85.5% 106.6% 165.9% 137.2%
– – 29.2% 108.7% 17.9% 34.7% 70.4% 35.1% 71.8% 166.2% 33.2% 23.9% 22.6% 38.9% 40.5% 20.3% 12.4% 23.1% 14.1% 28.7% 24.0%
– – 3.7% 76.4% 7.9% 0.9% 21.8% – 33.9% 58.1% 0.1% 0.3% 0.4% 0.9% 2.6% 2.1% 1.3% 16.7% 3.6% 9.7% 7.2%
– – 9.5% 5.7% 4.2% 5.2% 7.4% 9.9% 14.1% 44.3% 13.1% 3.7% 5.8% 6.5% 3.9% 2.3% 3.2% 1.0% 2.0% 2.1% 1.5%
– – – 0.5% 12.6% 20.5% 50.2% 75.6% 90.1% 238.1% 101.6% 118.2% 72.3% 155.3% 115.5% 130.5% 74.8% 37.4% 56.4% 60.1% 64.0%
– – -257.5% -420.5% 69.5% 44.8% -20.6% -807.4% -111.2% -384.6% -53.5% -55.7% -2.4% 677.7% -79.6% -66.7% 5.7% 14.5% -6.6% -65.9% -37.2%
– – -270.3% -448.5% -190.7% -322.9% -652.8% -807.4% -1,538.4% -2,958.0% -822.8% -698.4% -449.9% 677.7% -536.3% -482.0% -162.9% -107.6% -199.2% -328.6% -280.6%
– – 52.6% 49.6% 11.6% 46.9% 82.3% 90.9% 172.7% 299.7% 76.7% 60.1% 39.1% 50.6% 36.2% 31.6% 14.9% 10.6% 16.6% 21.0% 19.5%

Data as of: October 2, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?